Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial

1988, Management of dyspepsia: report of a working party, Lancet, 1, 576 Heading, 1999, Prevalence of upper gastrointestinal symptoms in the general population: a systematic review, Scand J Gastroenterol Suppl, 231, 3 2000 Laheij, 1997, Cost of endoscopy in economic evaluation, Gastroenterology, 113, 2023 Delaney, 2005, Initial management strategies for dyspepsia, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD001961.pub2 Talley, 2005, Guidelines for the management of dyspepsia, Am J Gastroenterol, 100, 2324, 10.1111/j.1572-0241.2005.00225.x Chey, 2004, Review article: uninvestigated dyspepsia and non-ulcer dyspepsia—the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy, Aliment Pharmacol Ther, 19, 1, 10.1111/j.0953-0673.2004.01829.x 2000 Makris, 2003, Cost-effectiveness of alternative approaches in the management of dyspepsia, Int J Technol Assess Health Care, 19, 446, 10.1017/S0266462303000394 Talley, 2005, American Gastroenterological Association medical position statement: evaluation of dyspepsia, Gastroenterology, 129, 1753, 10.1053/j.gastro.2005.09.019 van Zanten, 2005, Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool, Can J Gastroenterol, 19, 285, 10.1155/2005/674607 2004 2003 2004 Fransen, 2007, Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study, BMC Med Res Methodol, 7, 16, 10.1186/1471-2288-7-16 Heading, 1991, Definitions of dyspepsia, Scand J Gastroenterol Suppl, 182, 1, 10.3109/00365529109109529 Straus, 2002, Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions, Am J Gastroenterol, 97, 1951, 10.1111/j.1572-0241.2002.05905.x Bovenschen, 2006, Evaluation of a gastrointestinal symptoms questionnaire, Dig Dis Sci, 51, 1509, 10.1007/s10620-006-9120-6 Brooks, 1996, EuroQol: the current state of play, Health Policy, 37, 53, 10.1016/0168-8510(96)00822-6 Lamers, 2005, Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff, Ned Tijdschr Geneeskd, 149, 1574 Oostenbrink, 2004 2006 2006 Goves, 1998, First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice, Aliment Pharmacol Ther, 12, 147, 10.1046/j.1365-2036.1998.0284f.x Meineche-Schmidt, 2000, Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial, Am J Gastroenterol, 95, 2777 Armstrong, 2005, Heartburn-dominant, uninvestigated dyspepsia: a comparison of “PPI-start” and “H2-RA-start” management strategies in primary care—the CADET-HR Study, Aliment Pharmacol Ther, 21, 1189, 10.1111/j.1365-2036.2005.02466.x Mason, 1998, The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected], Aliment Pharmacol Ther, 12, 263, 10.1046/j.1365-2036.1998.00282.x Howden, 2001, Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies, Am J Gastroenterol, 96, 1704, 10.1111/j.1572-0241.2001.03861.x Inadomi, 2003, Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs, Am J Gastroenterol, 98, 1940, 10.1111/j.1572-0241.2003.07665.x Festen, 1999, Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group, Am J Gastroenterol, 94, 931, 10.1111/j.1572-0241.1999.989_l.x Beck, 2002, In support of “step-up therapy” for gastroesophageal reflux disease, Am J Gastroenterol, 97, 503 Jones, 2001, Review article: acid suppression in the management of gastro-oesophageal reflux disease—an appraisal of treatment options in primary care, Aliment Pharmacol Ther, 15, 765, 10.1046/j.1365-2036.2001.00985.x Talley, 1998, Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies), Aliment Pharmacol Ther, 12, 1055, 10.1046/j.1365-2036.1998.00410.x van Zanten, 2005, A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study, Am J Gastroenterol, 100, 1477, 10.1111/j.1572-0241.2005.40280.x Laheij, 2004, Predominant symptom behavior in patients with persistent dyspepsia during treatment, J Clin Gastroenterol, 38, 490, 10.1097/01.mcg.0000123164.86324.24 Grainger, 1994, Prevalence of dyspepsia: the epidemiology of overlapping symptoms, Postgrad Med J, 70, 154, 10.1136/pgmj.70.821.154 Westbrook, 2000, The impact of dyspepsia definition on prevalence estimates: considerations for future researchers, Scand J Gastroenterol, 35, 227, 10.1080/003655200750024065 Panter, 2004, Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome, Aliment Pharmacol Ther, 19, 981, 10.1111/j.1365-2036.2004.01924.x Holdstock, 1981, Endoscopy and gastric cancer, Gut, 22, 673, 10.1136/gut.22.8.673 Delaney, 2008, Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial), BMJ, 336, 651, 10.1136/bmj.39479.640486.AE